- Country: USA
- Summary: Heal Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial not Allowed)
- UST Ref No: 71765007
- Deadline: 04 Apr 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: RFA-NS-23-006
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tender are invited for HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)
CFDA Number : 93.213 -- Research and Training in Complementary and Integrative Health93.233 -- National Center on Sleep Disorders Research93.242 -- Mental Health Research Grants93.273 -- Alcohol Research Programs93.350 -- National Center for Advancing Translational Sciences93.351 -- Research Infrastructure Programs93.837 -- Cardiovascular Diseases Research93.838 -- Lung Diseases Research93.839 -- Blood Diseases and Resources Research93.840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders93.846 -- Arthritis, Musculoskeletal and Skin Diseases Research93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders93.859 -- Biomedical Research and Research Training93.865 -- Child Health and Human Development Extramural Research93.866 -- Aging Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Apr 04, 2025
Posted Date : Sep 15, 2022
Description: The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Innovation Research (SBIR) program. This FOA is focused on a... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINHeal Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial not Allowed) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Heal Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial not Allowed). This tender is published on USARFP under UST Ref No: 71765007 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-04.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
